Phil is a Founding Partner at Anterra Capital where he currently leads Anterra’s US office. He invests primarily at the intersection of life science technologies and agriculture with a strong focus on genetics, crop protection and animal health innovations. Besides his role as Board member at Vestaron, Phil currently represents Anterra on the Boards of Caribou Biosciences, Agrimetis, and Enko Chem. Phil has 10 years of investment experience having previously worked at Rabobank International and Atlas Ventures. He started his career at McKinsey & Company following a degree in Chemical Engineering and Pharmaceutical Chemistry.